Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Dapagliflozin propanediol + metformin hydrochloride) ER by Yooyoung Pharm for Type 2 Diabetes: Likelihood of Approval
(Dapagliflozin propanediol + metformin hydrochloride) ER is under clinical development by Yooyoung Pharm and currently in Phase III for Type...